| Exploring selective inhibition of the first bromodomain of the human bromodomain and extra-terminal domain (BET) proteins B Raux, Y Voitovich, C Derviaux, A Lugari, E Rebuffet, S Milhas, S Priet, ... Journal of medicinal chemistry 59 (4), 1634-1641, 2016 | 96 | 2016 |
| Integrated strategy for lead optimization based on fragment growing: the diversity-oriented-target-focused-synthesis approach L Hoffer, YV Voitovich, B Raux, K Carrasco, C Muller, AY Fedorov, ... Journal of medicinal chemistry 61 (13), 5719-5732, 2018 | 59 | 2018 |
| Protein–Protein Interaction Inhibition (2P2I)-Oriented Chemical Library Accelerates Hit Discovery S Milhas, B Raux, S Betzi, C Derviaux, P Roche, A Restouin, MJ Basse, ... ACS chemical biology 11 (8), 2140-2148, 2016 | 43 | 2016 |
| Slowing down fat digestion and absorption by an oxadiazolone inhibitor targeting selectively gastric lipolysis V Point, A Bénarouche, J Zarrillo, A Guy, R Magnez, L Fonseca, B Raux, ... European journal of medicinal chemistry 123, 834-848, 2016 | 21 | 2016 |
| Supported inhibitor for fishing lipases in complex biological media and mass spectrometry identification V Delorme, B Raux, R Puppo, J Leclaire, JF Cavalier, S Marc, ... Biochimie 107, 124-134, 2014 | 2 | 2014 |
| Xanthine derivative inhibitors of BET proteins X Morelli, S Combes, JC Guillemot, S Betzi, Y Collette, P Roche, A Lugari, ... US Patent 11,225,481, 2022 | | 2022 |
| Développement d'inhibiteurs d'interaction protéine-protéine ciblant les protéines à bromodomaines: implications en épigénétique et dans le développement de cancers B Raux Aix-Marseille, 2017 | | 2017 |
| Exploring Selectivity of the First Bromo and Extra-Terminal (BET) Bromodomain Inhibition B Raux, Y Voitovich, C Derviaux, A Lugari, E Rebuffet, S Milhas, S Priet, ... | | |
| Chemistry-driven Hit-to-Lead Optimization L Hoffer, YV Voitovich, B Raux, M Saez-Ayala, K Carrasco, C Muller, ... | | |
